Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against GRAIL, Inc. alleging that company executives made materially false and misleading statements regarding the NHS-Galleri trial's likelihood of success. The complaint claims defendants misrepresented the trial's prospects and concealed adverse data suggesting the three-year timeframe was insufficient to achieve the primary endpoint. Investors who purchased GRAIL securities between May 13, 2025 and February 19, 2026 are eligible to join the case, with a lead plaintiff deadline of August 4, 2026.